drugset / Trial / NCT02541396

A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy

NCT02541396

Phase 2 Completed 72 enrolled iX Biopharma Ltd. Jean Brown Research · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the safety and effectiveness of Wafermine administered with and without an opioid medication for acute pain following bunionectomy surgery.

Timeline

Start
2015-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 5 mg
Subject Wafermine Unknown 35 mg Other
Subject Wafermine Unknown 70 mg Other

Indications

No indication recorded.